Peter G Daddona

20130171136, Jul 4, 2013

Mar 5, 2013

13/786440

Janssen Biotech, Inc. - Malvern PA, US
New York University - New York NY, US
Peter E. Daddona - Menlo Park CA, US
John Ghrayeb - Downingtown PA, US
David M. Knight - Berwyn PA, US
Scott A. Siegel - Ringoes NJ, US

NEW YORK UNIVERSITY - New York NY
JANSSEN BIOTECH, INC. - Malvern PA

A61K 39/395

4241331

Anti-TNF antibodies, fragments and regions thereof which are specific for human tumor necrosis factor-α (TNFα) and are useful in vivo diagnosis and therapy of a number of TNFα-mediated pathologies and conditions, as well as polynucleotides coding for murine and chimeric antibodies, methods of producing the antibody, methods of use of the anti-TNF antibody, or fragment, region or derivative thereof, in immunoassays and immunotherapeutic approaches are provided.

20130183298, Jul 18, 2013

Mar 5, 2013

13/786445

Janssen Biotech, Inc. - Malvern PA, US
New York University - New York NY, US
Peter E. Daddona - Menlo Park CA, US
John Ghrayeb - Downingtown PA, US
David M. Knight - Berwyn PA, US
Scott A. Siegel - Ringoes NJ, US

NEW YORK UNIVERSITY - New York NY
JANSSEN BIOTECH, INC. - Malvern PA

A61K 39/395
A61K 31/519
A61K 45/06
A61K 45/00

4241331

Anti-TNF antibodies, fragments and regions thereof which are specific for human tumor necrosis factor-α (TNFα) and are useful in vivo diagnosis and therapy of a number of TNFα-mediated pathologies and conditions, as well as polynucleotides coding for murine and chimeric antibodies, methods of producing the antibody, methods of use of the anti-TNF antibody, or fragment, region or derivative thereof, in immunoassays and immunotherapeutic approaches are provided.

50265377, Jun 25, 1991

Apr 6, 1989

7/334459

Peter E. Daddona - West Chester PA
Harvey J. Berger - Devon PA
Rodger P. McEver - Oklahoma City OK

Centocor, Inc. - Malvern PA

A61K 4902

424 11

This invention pertains to a method of imaging atherosclerotic plaque using radiolabeled monoclonal antibodies that are specific for activated platelets or activated endothelial cells. The method is capable of determining the site of endothelial injury. This method involves the administration of a platelet-specific labeled monoclonal antibody or antibody fragment to a patient. The antibody is allowed to accumulate at the plaque site and the plaque is then scanned with a photoscanner. The detected signals are then converted into an image of the plaque.

49466682, Aug 7, 1990

Nov 22, 1988

7/274763

Peter E. Daddona - West Chester PA
Koon Y. Pak - Bluebell PA
Mark Nedelman - Downingtown PA

Centocor, Inc. - Malvern PA

A61K 4902
C07F 1300

424 11

Method using technetium-99m imaging agents for the study, detection or diagnosis of tumors. The imaging agents comprise a complex of technetium-99m and glucarate.